The following table provides segment revenues, significant segment expenses, other segment items and reported segment net income for the Company’s one reportable segment, as well as a reconciliation of segment net income to the Company’s total consolidated net income for the three and nine months ended September 30, 2025 and 2024 (in millions):


	Three months ended September 30,				Nine months ended September 30,
	2025		2024		2025		2024
Revenues:
Product sales	$	9,137	$	8,151	$	25,781	$	23,310
Other revenues	420		352		1,104		1,028
Total revenues	9,557		8,503		26,885		24,338

Less:
Manufacturing cost of sales(1)(2)	2,508		2,852		7,520		8,491
Profit share and royalties in cost of sales(1)	574		458		1,541		1,255
Research and development(1)	1,900		1,450		5,130		4,240
Sales and marketing(1)	1,097		1,117		3,300		3,532
General and administrative(1)	623		508		1,798		1,686
Other segment items(3)	(1,642)		(1,661)		(1,676)		(696)
Equity in (income) loss of equity method investments	(10)		28		19		(11)
Interest income	(99)		(126)		(311)		(394)
Interest expense, net	685		776		2,102		2,408
Provision for income taxes	705		271		1,084		364
Segment net income	3,216		2,830		6,378		3,463
Reconciliation of profit or loss:
Adjustments and reconciling items	—		—		—		—
Consolidated net income	$	3,216	$	2,830	$	6,378	$	3,463

(1) During the three months ended September 30, 2025 and 2024, amortization of our finite-lived intangible assets was $1.1 billion and $1.2 billion, respectively. During the nine months ended September 30, 2025 and 2024, amortization of our finite-lived intangible assets was $3.4 billion and $3.6 billion, respectively. Amortization of intangible assets is primarily included in Cost of sales in the Condensed Consolidated Statements of Income. In addition, during the three months ended September 30, 2025 and 2024, we recognized depreciation and right-of-use asset amortization of $232 million and $198 million, respectively. During the nine months ended September 30, 2025 and 2024, we recognized depreciation and right-of-use asset amortization of $661 million and $601 million, respectively.

(2) During the three months ended September 30, 2025 and 2024, manufacturing cost of sales included amortization of step-up to fair value of inventory acquired in business combinations of $338 million and $661 million, respectively. During the nine months ended September 30, 2025 and 2024, manufacturing cost of sales included amortization of step-up to fair value of inventory acquired in business combinations of $1.0 billion and $2.0 billion, respectively.

(3) Other segment items included in Segment net income primarily consisted of fair value adjustments on equity securities (see Note 6, Investments) and net impairment charges on intangible assets (see Note 8, Goodwill and other intangible assets).